6 October 2014Big Pharma

Teva gets under Leo’s skin, knocks out two patents

Drug business Teva invalidated two patents held by Leo Pharma today (October 6) and will seek to launch a generic version of one of the company’s skin condition treatments.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
22 November 2018   Denmark-based Leo Pharma and Californian rare disease company PellePharm have partnered to develop and commercialise therapies for rare forms of skin cancer.